SCHEMBL24157288

SCHEMBL24157288

c1ccc(C2(c3ccccc3)CCCCCCCCCCC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.58
ESR2 Q92731 2/20 0.58
OPRM1 P35372 2/20 0.58
ALDH1A1 P00352 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
MEN1 O00255 1/20 0.56
CYP2C9 P11712 1/20 0.56
KMT2A Q03164 1/20 0.56
GRIN2D O15399 1/20 0.50
GRIN3B O60391 1/20 0.50
CYP2B6 P20813 1/20 0.50
SLC6A2 P23975 1/20 0.50
SLC6A4 P31645 1/20 0.50
PRCP P42785 1/20 0.50
SLC6A3 Q01959 1/20 0.50
GRIN1 Q05586 1/20 0.50
KCNH2 Q12809 1/20 0.50
GRIN2A Q12879 1/20 0.50
GRIN2B Q13224 1/20 0.50
GRIN2C Q14957 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30877902 1.00 ESR1 (0.58) ESR1ESR2OPRM1ALDH1A1L3MBTL1
SCHEMBL30078304 1.00 ESR1 (0.58) ESR1ESR2OPRM1ALDH1A1L3MBTL1
SCHEMBL30877914 1.00 ESR1 (0.58) ESR1ESR2OPRM1ALDH1A1L3MBTL1
SCHEMBL54982 1.00 ESR1 (0.58) ESR1ESR2OPRM1ALDH1A1L3MBTL1
SCHEMBL28378542 1.00 ESR1 (0.58) ESR1ESR2OPRM1ALDH1A1L3MBTL1
Ammonia Solution, Strong SCHEMBL7989528 0.97 ESR1 (0.56) ESR1ESR2OPRM1ALDH1A1L3MBTL1
Ammonia Solution, Strong SCHEMBL8967959 0.97 ESR1 (0.56) ESR1ESR2OPRM1ALDH1A1L3MBTL1
SCHEMBL1515174 0.97 ESR1 (0.56) ESR1ESR2OPRM1ALDH1A1L3MBTL1
Hydrogen Peroxide SCHEMBL2349581 0.97 ESR1 (0.62) ESR1ESR2OPRM1ALDH1A1L3MBTL1
Ammonia Solution, Strong SCHEMBL8137073 0.97 ESR1 (0.56) ESR1ESR2OPRM1ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118613486-A 2, 7-Substituted pyrrolo [2,1-F ] [1,2,4] triazine compounds having protein kinase inhibitory activity 魔法弹丸治疗 2024-09-06 CN claimed
CN-118613486-A 2, 7-Substituted pyrrolo [2,1-F ] [1,2,4] triazine compounds having protein kinase inhibitory activity 魔法弹丸治疗 2024-09-06 CN disclosed
CN-113939553-B Polycarbonate resin 三菱瓦斯化学株式会社 2024-03-29 CN disclosed
WO-2023026923-A1 CURABLE RESIN COMPOSITION, CURED PRODUCT, CURABLE COMPOSITE MATERIAL, CURED COMPOSITE MATERIAL, VARNISH FOR CIRCUIT BOARD MATERIALS, MULTILAYER BODY, METAL FOIL WITH RESIN, ELECTRIC/ELECTRONIC COMPONENT, AND CIRCUIT BOARD MATERIAL 日鉄ケミカル&マテリアル株式会社 2023-03-02 WO disclosed
CN-113939553-A Polycarbonate resin 三菱瓦斯化学株式会社 2022-01-14 CN disclosed
US-20210403409-A1 METHOD FOR PRODUCING CARBONATE DERIVATIVE NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) 2021-12-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210403409-A1 METHOD FOR PRODUCING CARBONATE DERIVATIVE CA4, CA3, CYP11B2 ESR1 1082/4885ESR2 1043/4885OPRM1 3102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.